Lipae, Abbygail A.

HRN: 22-63-91  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/18/2023
08/24/2023
IV
60mg
Q24
Pcap
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: